Abstract. Cerebral ischemia/reperfusion (I/R) injury results in detrimental complications. However, little is known about the underlying molecular mechanisms involved in the reperfusion stage. The aim of the present study was to identify a gene expression profile associated with cerebral ischemia/reperfusion injury. The GSE23160 dataset, which comprised data from sham control samples and post-I/R injury brain tissues that were obtained using a middle cerebral artery occlusion (MCAO) model at 2, 8 and 24 h post-reperfusion, was downloaded from the Gene Expression Omnibus database. The differentially expressed genes (DEGs) in the MCAO samples compared with controls were screened using the GEO2R web tool. Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis for DEGs was performed using the online tool DAVID. Furthermore, a protein-protein interaction (PPI) network was constructed using the STRING database and Cytoscape software. In total, 32 DEGs at 2 h post-reperfusion, 39 DEGs at 8 h post-reperfusion and 91 DEGs at 24 h post-reperfusion were identified, while 15 DEGs were common among all three groups. GO analysis revealed that the DEGs at all three time-points were enriched in 'chemotaxis' and 'inflammatory response' terms, while KEGG pathway analysis demonstrated that DEGs were significantly enriched in the 'chemokine signaling pathway'. Furthermore, following PPI network construction, Cxcl1 was identified as the only hub gene that was common among all three time-points. In conclusion, the present study has demonstrated a global view of the potential molecular differences following cerebral I/R injury and may contribute to an improved understanding of the reperfusion stage, which may ultimately aid in the development of future clinical strategies.
Introduction
Globally, stroke is the second most frequent cause of mortality and the primary cause of serious long-term disability worldwide (1) . Of all strokes, 87% are ischemic (2) . Various mechanisms underlying ischemic stroke are driven by cell-cell interactions within brain, including excitotoxicity, calcium dysregulation, oxidative and nitrosative Stress, cortical spreading depolarizations, inflammation, necrosis, necroptosis and autophagy (3) . In addition to a narrow therapeutic time window (4) , ischemic stroke remains difficult to manage.
Although reperfusion has been proven to be beneficial for ischemic stroke (5) , reperfusion may result in detrimental secondary damage, which is termed ischemia/reperfusion (I/R) injury. Early reperfusion of ischemic brain tissue has been associated with various negative consequences, including blood-brain barrier breakdown, which may result in cerebral edema and/or brain hemorrhage, neurovascular damage and neuronal death (6) . Angiogenesis and vasculogenesis have also been detected following reperfusion (7) . In addition, inflammation is induced by reperfusion injury and contributes negatively to long-term disease prognosis (8) . The inflammatory response may result in subsequent oxidative injury, excitotoxicity and neuronal cell death (9) . Chemokines, produced by resident microglial cells and other immune cells in the brain, contribute to the recruitment of circulating leukocytes and exaggerate the inflammatory response. Chemokines have been demonstrated to have both deleterious and beneficial roles in ischemia/reperfusion injury (10) .
Microarray analysis has been previously employed to identify molecular variations in cerebral I/R injury (11, 12) . However, gene expression profiles at different reperfusion periods have not been investigated extensively. Therefore, the present study employed a microarray dataset from the Gene Expression Omnibus (GEO) database and screened for differentially expressed genes (DEGs) between control samples and Identification and functional analysis of differentially expressed genes associated with cerebral ischemia/reperfusion injury through bioinformatics methods (17) .
Construction of the PPI network.
To further investigate the underlying molecular mechanisms of cerebral I/R injury, protein-protein interaction (PPI) networks for the DEGs were constructed using the Search Tool for the Retrieval of Interacting Genes (STRING) database (http://www.string-db.org/) (18) . A combined score of >0.4 was selected to construct the PPI networks. The obtained PPI networks at 24 h post-reperfusion were subsequently visualized using Cytoscape software (version 3.5.1) (19) . Finally, the topological properties of the networks at 2, 8 and 24 h post-reperfusion were analyzed and the degree of each node was calculated; genes with a degree >10 were defined as hub genes.
Results

Identification of DEGs.
As demonstrated in Fig. 1 Table II . Furthermore, 'chemotaxis' (GO:0006935), 'inflammatory response' (GO:0006954), 'immune response' (GO:0006955), 'G-protein coupled receptor signaling pathway' (GO:0007186), 'response to toxic substance' (GO:0009636), 'neutrophil chemotaxis' (GO:0030593), 'positive regulation of tumor necrosis factor production' (GO:0032760), 'positive regulation of GTPase activity' (GO:0043547), 'lymphocyte chemotaxis' (GO:0048247), 'positive regulation of inflammatory response' (GO:0050729), 'cell chemotaxis' (GO:0060326), 'chemokine-mediated signaling pathway' (GO:0070098), 'positive regulation of ERK1 and ERK2 cascade' (GO:0070374), 'cellular response to interferon-gamma' (GO:0071346), 'cellular response to interleukin-1' (GO:0071347), 'monocyte chemotaxis' (GO:0002548) and 'cellular response to tumor necrosis factor' (GO:0071356) were significantly enriched at all three post-reperfusion time-points (2, 8 and 24 h).
Additionally, DEGs were enriched in various GO cellular component terms; at 2 and 8 h post-reperfusion, DEGs were enriched in 'extracellular region' (GO:0005576), while Table I . DEGs between cerebral I/R and sham control samples that were common among 2, 8 and 24 h post-reperfusion time-points. CXCL1, CCL12, CCL3, S100A8, LGALS3, CCL9, CCL4, CCL7, FCGR3, CCL17
'membrane' (GO:0016020) was significantly enriched at both 8 and 24 h post-reperfusion (Table III) . Furthermore, Table IV indicates that DEGs were significantly enriched in 'cytokine activity' (GO:0005125) and 'chemokine activity'
(GO:0008009) GO molecular function terms at 2, 8 and 24 h post-reperfusion. CCL12, CCL3, CCL2, CCL21C, CCL9, CCL21A, interferon-gamma CCL4, GBP2, CCL7
GO, Gene Ontology; DEGs, differentially expressed genes.
signaling pathway', 'cytokine-cytokine receptor interaction' and 'toll-like receptor signaling pathway' were significantly enriched in DEGs at 2, 8 and 24 h post-reperfusion. Furthermore, as demonstrated in Fig. 2 , a total of 11 chemokine signaling pathway-associated genes were overexpressed in 24 h post-reperfusion injury samples compared with the sham control samples.
PPI network analysis.
Genes with an interaction degree >10 in the PPI network analysis of DEGs at 2, 8 and 24 h post-reperfusion were defined as hub genes, which are listed in Table VI. CXCL1 was the only gene that was considered to be a hub gene at 2, 8 and 24 h post-reperfusion (Table VI) . The constructed PPI network of 24 h post-reperfusion samples is presented in -3 GPR182, GPR84, S100A8, IFITM2, TNFRSF12A, IFITM3,  VIM, S100A9, TLR2, CD52, FPR2, SLC11A1, P2RY6, DAB2,  PLIN2, HMOX1, TGM2, STRA6, CLEC4D, ANGPT2, ACTB,  PDPN, LILRB4A, GJB2, ANXA2, CYBA, THBD, FCGR2B,  HSPB1, SCN4B, RGS9, EMP3, CD14, EMP1  GO:0016020 Membrane  44  47.83 1.14x10  -2 GPR182, GPR84, GFAP, TSPO, S100A8, IFITM2, TNFRSF12A,  IFITM3, S100A9, TLR2, CD52, FPR2, FXYD5, GLIPR2,  SLC11A1, P2RY6, DAB2, PLIN2, HMOX1, CH25H, TGM1,  TGM2, STRA6, CLEC4D, ACTB, LGALS3, PDPN, MS4A6D,  LILRB4A, GJB2, ANXA2, HBA-A1, CYBA, RAB32, THBD,  FCGR2B, SCN4B, RGS9, EMP3, SLC15A3, GBP2, CD14,  EMP1, MVP GO, Gene Ontology; DEGs, differentially expressed genes. Fig. 3 , which contains 67 nodes and 281 edges. Each node represents a DEG and each edge represents a PPI between two DEGs. At 24 h post-reperfusion, 23 genes served as hub genes, and of these hub genes, CCL2 exhibited the highest degree (Fig. 3) .
Discussion
In the present study, 32 DEGs at 2 h, 39 DEGs at 8 h and 91 DEGs at 24 h post-reperfusion injury were identified between cerebral I/R and sham control samples. Previous studies have performed bioinformatics analysis to identify DEGs between MCAO models and controls (11, (20) (21) (22) (23) . However, to the best of our knowledge, the present study is the first to perform global gene expression profiling at three time-points following reperfusion, and the findings may lead to improvements in the understanding of the pathophysiological process of cerebral I/R injury. DEGs associated with inflammation have previously been associated with cerebral I/R injury (20, 22) , and the results of the present study were consistent with these previous reports, indicating a persistent inflammatory response in cerebral I/R injury. In the current study, enrichment analysis revealed that 'chemotaxis', 'chemokine activity' and 'chemokine signaling pathway' terms were significantly enriched for the obtained DEGs. Furthermore, members of the chemokine family were the most abundant among the upregulated genes that were common among 2, 8 and 24 h post-reperfusion time-points, including CCL3, CCL4, CCL7 and CXCL1. Chemokines have been reported to have complex and essential roles in I/R injury, which involves extensive leukocyte and neutrophil infiltration, subsequently exaggerating the ischemic area (24) . Following ischemic stroke, chemokines are primarily produced by resident microglial cells in the brain and infiltrating immune cells, which leads to further leukocyte recruitment and activation (25) . In the present study, CCL2 exhibited the highest degree in the PPI network at 24 h post-reperfusion, which is consistent with previous studies (26, 27) . Accordingly, CCL2 mRNA expression was initially increased at 6 h post-reperfusion, peaking 2 days later. Additionally, CCL3 was previously described to be upregulated post-I/R injury via the induction of monocyte accumulation in the ischemic brain (28, 29) , and the expression of CCL3 post-reperfusion has been reported to be time-dependent (30) . CCL7, as a mast cell-derived product, has been reported to be involved in the recruitment of inflammatory cells into the ischemic sites (31), subsequently contributing to stroke pathology (32) . CXCL1, identified as a hub gene in the PPI networks at 2, 8 and 24 h post-reperfusion in the present study, was reported to be increased in the cerebrospinal fluid of patients that have suffered from a stroke (33) . However, both neurotoxic and neuroprotective effects have been demonstrated for chemokines in post-stroke inflammation (28) . It is established that inflammation is a major contributor to stroke pathophysiology, and the immune system has been implicated in all stages of the ischemic cascade, from the acute damaging events to the progression of tissue repair (34) . Microglia cells, which are closely associated with inflammation, were reported to become rapidly activated following ischemia (35) . Furthermore, various pro-inflammatory factors, including interleukin (IL)-1β, IL-6, tumor necrosis factor-α, reactive oxygen species, nitric oxide and prostaglandin E2, were reported to be produced by activated microglia and contribute to neuronal death in cerebral ischemia (36) . In the present study, specific cytokines were not measured. Further studies are required to investigate the association between the chemokine family and pro-inflammatory cytokines, which further elucidate the pathophysiological process following cerebral I/R injury.
The results of the present study revealed that the toll-like receptor signaling pathway was significantly enriched at 2 h post-reperfusion, suggesting early transcriptional activation. TLR2, a vital factor in the inflammatory response and tissue damage, has been reported to be implicated in cerebral ischemic damage (37) . Microglia cells produce cytokines and chemokines following the stimulation of TLR2 (38). Furthermore, leukocyte and microglial infiltration, and neuronal death, were reported to be attenuated by TLR2 inhibition (39) , indicating a potential novel therapeutic strategy.
In conclusion, the current study identified a set of DEGs that were altered between cerebral I/R injury samples and sham control samples. The findings may provide novel insight into the potential mechanisms underlying the development of cerebral I/R injury. Our future studies will be aimed at unveiling the potential diagnostic and prognostic value of these hub genes, which may ultimately aid the translation of these targets into clinical practice. CCL2  37  TLR2  28  CCL3  19  CD14  19  CXCL10  19  CXCL1  18  CCL7  17  CCL4  17  SLC11A1  16  TIMP1  16  MS4A6D  14  LCN2  14  LILRB4  14  FPR2  14  SOCS3  13  SLC15A3  12  VIM  12  FCGR2B  12  CCL9  12  CCL12  11  PF4  11  LGALS3  10  ACTB  10 PPI, protein-protein interaction.
